Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vimonsri Rangsrisaeneepitak"'
Autor:
Vimonsri Rangsrisaeneepitak, Arnant Tekarnjnavanit, Pattarapol Kanjanapipatkul, Sukrisd Koowattanatianchai
Publikováno v:
European Journal of Case Reports in Internal Medicine (2024)
Osmotic demyelination syndrome (ODS) is a disorder characterised by the widespread development of demyelination in both pontine and extrapontine regions. It has been recognised as a complication arising from the rapid correction of hyponatraemia. Thi
Externí odkaz:
https://doaj.org/article/26fda7ae98dd4e26acebc5c1f129b140
Autor:
Supamas Sirisreetreerux, Thachanun Porntharukchareon, Bothamai Dechates, Vimonsri Rangsrisaeneepitak, Phonthip Therawit, Supanat Worawitchawong, Gaidganok Sornsamdang, Kamonwan Soonklang, Kriangkrai Tawinprai
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract The ChAdOx1 nCoV-19 vaccine (AZD1222) was used in Thailand during the early outbreak of coronavirus disease 2019 (COVID-19). A previous study showed a low immune response in diabetes patients after the first dose of the AZD1222 vaccine. Furt
Externí odkaz:
https://doaj.org/article/3a63a54d063f444eae7b36928da9d945
Autor:
Thachanun Porntharukchareon, Wipada Chartisathian, Manassamon Navinpipat, Chayanee Samdaengpan, Kunsuda Cheirsilpa, Aimwipa Lueprasitsakul, Supanat Worawichawong, Viroj Muangsillapasart, Pratya Pumuthaivirat, Bothamai Dechates, Supamas Sirisreetreerux, Taweegrit Siripongboonsitti, Vimonsri Rangsrisaeneepitak, Kerati Jirawattanapalin, Kriangkrai Tawinprai
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increases mortality rates in older adults and those with comorbidities. Individuals with certain comorbidities may have a poor immune response and require early booster vaccines. We aimed t
Externí odkaz:
https://doaj.org/article/d9fefc7a82fe41f29f104928efe1ccb9
Autor:
Vimonsri Rangsrisaeneepitak, Thachanun Porntharukchareon, Bothamai Dechates, Supamas Sirisreetreerux, Kriangkrai Tawinprai
Publikováno v:
Diabetology international. 13(4)
Patients with diabetes and coexistent coronavirus disease 2019 (COVID-19) have a higher risk of COVID-19 complications. Therefore, it is critical that sustained and effective immunogenicity against COVID-19 is achieved in such patients. This study ev